相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-Based Glycoproteomics
Nicholas M. Riley et al.
MOLECULAR & CELLULAR PROTEOMICS (2021)
Urinary proteome profiling for stratifying patients with familial Parkinson's disease
Sebastian Virreira Winter et al.
EMBO MOLECULAR MEDICINE (2021)
A practical guide to cancer subclonal reconstruction from DNA sequencing
Maxime Tarabichi et al.
NATURE METHODS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
Rebecca G. Philipson et al.
EUROPEAN UROLOGY (2021)
An integrated landscape of protein expression in human cancer
Andrew F. Jarnuczak et al.
SCIENTIFIC DATA (2021)
Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active Surveillance
Walter Hsiang et al.
EUROPEAN UROLOGY FOCUS (2021)
Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome
Jouhyun Jeon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
Armando Stabile et al.
NATURE REVIEWS UROLOGY (2020)
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer
Yu Ishizuya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Evaluation of Proclarix, a prostate cancer risk score, used together with magnetic resonance imaging for the diagnosis of clinically significant prostate cancer.
Hayley Pye et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A Compact Quadrupole-Orbitrap Mass Spectrometer with FAIMS Interface Improves Proteome Coverage in Short LC Gradients
Dorte B. Bekker-Jensen et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Automated sample preparation with SP3 for low-input clinical proteomics
Torsten Mueller et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
The single-cell pathology landscape of breast cancer
Hartland W. Jackson et al.
NATURE (2020)
All change in the prostate cancer diagnostic pathway
Derek J. Lomas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Michael Ahdoot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Divergent mutational processes distinguish hypoxic and normoxic tumours
Vinayak Bhandari et al.
NATURE COMMUNICATIONS (2020)
Trapped ion mobility spectrometry and PASEF enable in-depth lipidomics from minimal sample amounts
Catherine G. Vasilopoulou et al.
NATURE COMMUNICATIONS (2020)
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer
Amar U. Kishan et al.
EUROPEAN UROLOGY (2020)
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer
Annalisa Macagno et al.
PLOS ONE (2020)
Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer
Jinhui Zhang et al.
PROSTATE (2020)
Technologies and Standardization in Research on Extracellular Vesicles
Srujan Gandham et al.
TRENDS IN BIOTECHNOLOGY (2020)
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies
Yue Xuan et al.
NATURE COMMUNICATIONS (2020)
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
Thomas Steuber et al.
BJU INTERNATIONAL (2019)
The Proteogenomic Landscape of Curable Prostate Cancer
Ankit Sinha et al.
CANCER CELL (2019)
Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer
Manish Kohli et al.
CLINICAL GENITOURINARY CANCER (2019)
Transperineal Prostate Biopsies Using Local Anesthesia: Experience with 1,287 Patients. Prostate Cancer Detection Rate, Complications and Patient Tolerability
Veselina Stefanova et al.
JOURNAL OF UROLOGY (2019)
Analysis of 1508 Plasma Samples by Capillary-Flow Data-Independent Acquisition Profiles Proteomics of Weight Loss and Maintenance
Roland Bruderer et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management
Kevin M. Koo et al.
NATURE REVIEWS UROLOGY (2019)
A Fully Integrated Spintip-Based Approach for Sensitive and Quantitative Profiling of Region-Resolved in Vivo Brain Glycoproteome
Peiwu Huang et al.
ANALYTICAL CHEMISTRY (2019)
Plasma Proteome Profiling to detect and avoid sample-related biases in biomarker studies
Philipp E. Geyer et al.
EMBO MOLECULAR MEDICINE (2019)
Recent trends of capillary electrophoresis-mass spectrometry in proteomics research
Fabio P. Gomes et al.
MASS SPECTROMETRY REVIEWS (2019)
Improved Sensitivity in Low-Input Proteomics Using Micropillar Array-Based Chromatography
Johannes Stadlmann et al.
ANALYTICAL CHEMISTRY (2019)
Towards precision oncology in advanced prostate cancer
Sheng-Yu Ku et al.
NATURE REVIEWS UROLOGY (2019)
Integrative proteomic and phosphoproteomic profiling of prostate cell lines
Maria Katsogiannou et al.
PLOS ONE (2019)
The human secretome
Mathias Uhlen et al.
SCIENCE SIGNALING (2019)
Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging
David C. Johnson et al.
EUROPEAN UROLOGY (2019)
Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: What We See and What We Miss
Anwar R. Padhani et al.
EUROPEAN UROLOGY (2019)
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
R2-P2 rapid-robotic phosphoproteomics enables multidimensional cell signaling studies
Mario Leutert et al.
MOLECULAR SYSTEMS BIOLOGY (2019)
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Takeshi Namekawa et al.
CELLS (2019)
Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists
Geoffrey A. Sonn et al.
EUROPEAN UROLOGY FOCUS (2019)
Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
Stamatia Rontogianni et al.
COMMUNICATIONS BIOLOGY (2019)
iTRAQ-based Comparative Serum Proteomic Analysis of Prostate Cancer Patients with or without Bone Metastasis
Bo Yan et al.
JOURNAL OF CANCER (2019)
Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis
Leen Naji et al.
ANNALS OF FAMILY MEDICINE (2018)
The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression
Shadrielle Melijah G. Espiritu et al.
CELL (2018)
Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics
Sophie Moggridge et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Quantitative Proteomics of TRAMP Mice Combined with Bioinformatics Analysis Reveals That PDGF-B Regulatory Network Plays a Key Role in Prostate Cancer Progression
Yuan Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Patient-derived xenografts: A platform for accelerating translational research in prostate cancer
Alastair H. Davies et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry
Philipp Mertins et al.
NATURE PROTOCOLS (2018)
Shedding light on the cell biology of extracellular vesicles
Guillaume van Niel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Biomarkers as drug development tools: discovery, validation, qualification and use
Virginia B. Kraus
NATURE REVIEWS RHEUMATOLOGY (2018)
Personalization of prostate cancer therapy through phosphoproteomics
Wei Yang et al.
NATURE REVIEWS UROLOGY (2018)
Benchmarking common quantification strategies for large-scale phosphoproteomics
Alexander Hogrebe et al.
NATURE COMMUNICATIONS (2018)
Genetic and transcriptional evolution alters cancer cell line drug response
Uri Ben-David et al.
NATURE (2018)
In Aptamers They Trust: Caveats of the SOMAscan Biomarker Discovery Platform From SomaLogic
Abhishek Joshi et al.
CIRCULATION (2018)
Pathway-based subnetworks enable cross-disease biomarker discovery
Syed Haider et al.
NATURE COMMUNICATIONS (2018)
Long non-coding RNA urothelial carcinoma associated 1 ( UCA1) mediates radiation response in prostate cancer
Alireza Fotouhi Ghiam et al.
ONCOTARGET (2017)
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
Tamara Sequeiros et al.
ONCOTARGET (2017)
A Prostate Cancer Nimbosus'': Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L. K. Chua et al.
EUROPEAN UROLOGY (2017)
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors
Emilie Lalonde et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
Exploiting charge differences for the analysis of challenging post-translational modifications by capillary electrophoresis-mass spectrometry
Klaus Faserl et al.
JOURNAL OF CHROMATOGRAPHY A (2017)
Revisiting biomarker discovery by plasma proteomics
Philipp E. Geyer et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery
Michael L. Merchant et al.
NATURE REVIEWS NEPHROLOGY (2017)
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
Kathrin Endt et al.
PLOS ONE (2017)
Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine
Kathryn L. Pellegrini et al.
PROSTATE (2017)
Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance
Naseruddin Hoeti et al.
PROTEOMICS (2017)
Mitochondrial mutations drive prostate cancer aggression
Julia F. Hopkins et al.
NATURE COMMUNICATIONS (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
Jane Bayani et al.
NPJ BREAST CANCER (2017)
Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins
Jennifer S. Myers et al.
BMC CANCER (2017)
Genomic Instability in Cancer: Teetering on the Limit of Tolerance
Noemi Andor et al.
CANCER RESEARCH (2017)
Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies
Christopher P. Filson et al.
CANCER (2016)
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Annette Becker et al.
CANCER CELL (2016)
How the TRAMP Model Revolutionized the Study of Prostate Cancer Progression
Irwin H. Gelman
CANCER RESEARCH (2016)
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer
Justin M. Drake et al.
CELL (2016)
Modeling Development and Disease with Organoids
Hans Clevers
CELL (2016)
Current state of the art for enhancing urine biomarker discovery
Michael Harpole et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Comparing continuous and discrete analyses of breast cancer survival information
Vinayak Bhandari et al.
GENOMICS (2016)
ExoCarta: A Web-Based Compendium of Exosomal Cargo
Shivakumar Keerthikumar et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
Hima Bindu Musunuru et al.
JOURNAL OF UROLOGY (2016)
Mass-spectrometric exploration of proteome structure and function
Ruedi Aebersold et al.
NATURE (2016)
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
Andrej Jedinak et al.
BMC CANCER (2015)
Tracking the Origin of Metastatic Prostate Cancer
Johan Lindberg et al.
EUROPEAN UROLOGY (2015)
Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review
Ivo G. Schoots et al.
EUROPEAN UROLOGY (2015)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Futterer et al.
EUROPEAN UROLOGY (2015)
Recent progress in urinary proteome analysis for prostate cancer diagnosis and management
Maria Frantzi et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Identification of prostate cancer biomarkers in urinary exosomes
Anders Overbye et al.
ONCOTARGET (2015)
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
M. Shipitsin et al.
BRITISH JOURNAL OF CANCER (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Overdiagnosis and Overtreatment of Prostate Cancer
Stacy Loeb et al.
EUROPEAN UROLOGY (2014)
Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis
Samir Al Bashir et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Off-Line High-pH Reversed-Phase Fractionation for In-Depth Phosphoproteomics
Tanveer S. Batth et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry- based Assay Development Using a Fit- for- Purpose Approach
Steven A. Carr et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data
Hannes L. Roest et al.
NATURE BIOTECHNOLOGY (2014)
Seminal plasma as a diagnostic fluid for male reproductive system disorders
Andrei P. Drabovich et al.
NATURE REVIEWS UROLOGY (2014)
Application of proteomics in the study of rodent models of cancer
Mikkel G. Terp et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1
Xiaoyong Huang et al.
CANCER RESEARCH (2013)
Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based Study
Jennifer R. Rider et al.
EUROPEAN UROLOGY (2013)
Systematic Review of Complications of Prostate Biopsy
Stacy Loeb et al.
EUROPEAN UROLOGY (2013)
Proteome Digestion Specificity Analysis for Rational Design of Extended Bottom-up and Middle-down Proteomics Experiments
Uenige A. Laskay et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Benchmarking stable isotope labeling based quantitative proteomics
A. F. Maarten Altelaar et al.
JOURNAL OF PROTEOMICS (2013)
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence
Katharina Grupp et al.
MODERN PATHOLOGY (2013)
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets
Justin M. Drake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine
Simona Principe et al.
PROTEOMICS (2013)
Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2012)
Modeling Prostate Cancer in Mice: Limitations and Opportunities
Patrick J. Hensley et al.
JOURNAL OF ANDROLOGY (2012)
Identification of Prostate-Enriched Proteins by In-depth Proteomic Analyses of Expressed Prostatic Secretions in Urine
Simona Principe et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Systematic Comparison of Label-Free, Metabolic Labeling, and Isobaric Chemical Labeling for Quantitative Proteomics on LTQ Orbitrap Velos
Zhou Li et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Location and Pathological Characteristics of Cancers in Radical Prostatectomy Specimens Identified by Transperineal Biopsy Compared to Transrectal Biopsy
Tania Hossack et al.
JOURNAL OF UROLOGY (2012)
Global Stability of Plasma Proteomes for Mass Spectrometry-Based Analyses
Lisa J. Zimmerman et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Identification of Differentially Expressed Proteins in Direct Expressed Prostatic Secretions of Men with Organ-confined Versus Extracapsular Prostate Cancer
Yunee Kim et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence
Stephen A. Boorjian et al.
EUROPEAN UROLOGY (2011)
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer
Igor Cima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Automated Detection of Inaccurate and Imprecise Transitions in Peptide Quantification by Multiple Reaction Monitoring Mass Spectrometry
Susan E. Abbatiello et al.
CLINICAL CHEMISTRY (2010)
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Chengjian Tu et al.
JOURNAL OF PROTEOME RESEARCH (2010)
In-Depth Proteomic Analyses of Direct Expressed Prostatic Secretions
Richard R. Drake et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery
Rikke Leth-Larsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Stroma-epithelium crosstalk in prostate cancer
Yi-Nong Niu et al.
ASIAN JOURNAL OF ANDROLOGY (2009)
The evolving role of mass spectrometry in cancer biomarker discovery
Pei Wang et al.
CANCER BIOLOGY & THERAPY (2009)
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Andrew N. Hoofnagle et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease
Richard R. Drake et al.
JOURNAL OF PROTEOMICS (2009)
A Human Proteome Detection and Quantitation Project
N. Leigh Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Targeted proteomic strategy for clinical biomarker discovery
Ralph Schiess et al.
MOLECULAR ONCOLOGY (2009)
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma
Terri A. Addona et al.
NATURE BIOTECHNOLOGY (2009)
Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer
Umberto Capitanio et al.
UROLOGY (2009)
Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?
Steven A. Carr et al.
CLINICAL CHEMISTRY (2008)
Urine in Clinical Proteomics
Stephane Decramer et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Selected reaction monitoring for quantitative proteomics: a tutorial
Vinzenz Lange et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Mining the plasma proteome for cancer biomarkers
Samir M. Hanash et al.
NATURE (2008)
Discovery and validation of urinary biomarkers for propstate cancer
Dan Theodorescu et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Advantages of combined transmembrane topology and signal peptide prediction -: the Phobius web server
Lukas Kaell et al.
NUCLEIC ACIDS RESEARCH (2007)
Upgrading and downgrading of prostate needle biopsy specimens: Risk factors and clinical implications
Stephen J. Freedland et al.
UROLOGY (2007)
eComputational prediction of proteotypic peptides for quantitative proteomics
Parag Mallick et al.
NATURE BIOTECHNOLOGY (2007)
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
Emanuel F. Petricoin et al.
NATURE REVIEWS CANCER (2006)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer
Alexander Makarov et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2006)
Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations
JE Elias et al.
NATURE METHODS (2005)
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
IM Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The ABC's (and XYZ's) of peptide sequencing
H Steen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra
JD Venable et al.
NATURE METHODS (2004)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Ion suppression in mass spectrometry
TM Annesley
CLINICAL CHEMISTRY (2003)
Tandem mass tags:: A novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS
A Thompson et al.
ANALYTICAL CHEMISTRY (2003)
PRISM, a generic large scale proteomic investigation strategy for mammals
T Kislinger et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Biology of prostate-specific antigen
SP Balk et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
An automated multidimensional protein identification technology for shotgun proteomics
DA Wolters et al.
ANALYTICAL CHEMISTRY (2001)
Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: Lack of prediction of tumor significance for men with nonpalpable prostate cancer
M Noguchi et al.
JOURNAL OF UROLOGY (2001)
Diagnosing and treating chronic prostatitis: Do urologists use the four-glass test?
MM Collins et al.
UROLOGY (2000)
分享论文
